Invus Financial Advisors, LLC Oric Pharmaceuticals, Inc. Transaction History
Invus Financial Advisors, LLC
- $89.2 Million
- Q2 2024
A detailed history of Invus Financial Advisors, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Invus Financial Advisors, LLC holds 1,007,575 shares of ORIC stock, worth $10.4 Million. This represents 7.98% of its overall portfolio holdings.
Number of Shares
1,007,575
Previous 1,007,575
-0.0%
Holding current value
$10.4 Million
Previous $13.9 Million
48.59%
% of portfolio
7.98%
Previous 11.01%
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
116Shares Held
63.1MCall Options Held
0Put Options Held
0-
Nextech Invest Ag5.29MShares$54.4 Million7.05% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$49.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$45.3 Million3.41% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$42.7 Million1.73% of portfolio
-
Viking Global Investors LP4MShares$41.2 Million0.11% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $408M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...